Jean White
Interventional Cardiology · Lake Charles, LANPI 1003913070
Payments from drug & device makers
Across 209 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$485
- Johnson & Johnson$430
- Pfizer$308
- E.r. Squibb & Sons, L.L.C.$294
- Cardiovascular Systems Inc.$285
- Biotronik Inc.$282
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 30 | $485 |
| Johnson & Johnson | 29 | $430 |
| Pfizer | 21 | $308 |
| E.r. Squibb & Sons, L.L.C. | 24 | $294 |
| Cardiovascular Systems Inc. | 11 | $285 |
| Biotronik Inc. | 2 | $282 |
| Cook Medical LLC | 17 | $253 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $233 |
| Medtronic(2 entities) | 12 | $221 |
| Abiomed | 11 | $192 |
| Shockwave Medical, Inc | 5 | $168 |
| Amarin Pharma, Inc. | 5 | $86 |
| Boston Scientific | 5 | $79 |
| Truvic Medical, Inc. | 1 | $73 |
| Abbott | 3 | $65 |
| Merck | 3 | $58 |
| AstraZeneca | 3 | $40 |
| Boehringer Ingelheim | 3 | $40 |
| Amgen | 2 | $32 |
| Gilead | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| W. L. Gore & Associates, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Terumo Medical Corporation | 1 | $15 |
| Kerecis Limited | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orsiro$145
- Coronary Orbital Atherectomy System$139
- BioMonitor$137
- Edora$137
- Acticor$137
- Solia$137
- Rivacor$137
- Vascular Lithotripsy$100
How this compares
$3,775 in reported general payments places this provider in the 20th percentile of 171 interventional cardiology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $22,434 |
| EntrestoSacubitril/Valsartan | 17 | $14,538 |
| XareltoRivaroxaban | 16 | $13,344 |
| ClopidogrelClopidogrel Bisulfate | 80 | $477 |
| Ranolazine ErRanolazine | 13 | $340 |
| Metoprolol Succinate | 24 | $302 |
| Carvedilol | 41 | $253 |
| Atorvastatin Calcium | 13 | $149 |
| Metoprolol Tartrate | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $308 | $22,43444 claims |
| NovartisEntresto | $485 | $14,53817 claims |
| Johnson & JohnsonXarelto | $430 | $13,34416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 171 interventional cardiology providers in Louisiana.
Other interventional cardiology in Lake Charles
- Craig WalkerHouma$5.5M
- Naseem JaffraniAlexandria$5.1M
- Mark NapoliMonroe$2.2M
- Stephen RameeNew Orleans$1.5M
- Denzil MoraesBaton Rouge$1.4M
- James JenkinsNew Orleans$1.2M
- Ankur LodhaLafayette$945K
- Rajan PatelNew Orleans$633K
- Bruce EnnisMandeville$562K
- Jorge CastellanosBaton Rouge$561K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.